Medical specialists from France tagged as investigators in clinical trials studying Chronic Myeloid Leukemia
Total 88 results
-
Agnès Guerci-Bresler, MDSeen in:
- Nancy, Centre Hospital, Nancy
Trials:- NCT05963061 (Sub-Investigator)
Conditions: -
Agnès MACESeen in:
- Saint-Étienne, CHU de Saint-Etienne
Trials:- NCT05130138 (Sub-Investigator)
Conditions: -
Ali TURHAN, MDSeen in:
- Paris, Bicetre Hospital
- Paris, Hôpital Bicêtre
Trials:- NCT03481868 (Principal Investigator)
- NCT05963061 (Sub-Investigator)
Conditions: -
Alice GARNIER, MDSeen in:
- Nantes, CHU Hotel Dieu
Trials:- NCT05226455 (Principal Investigator)
- NCT05768711 (Principal Investigator)
- NCT05782127 (Principal Investigator)
Conditions: -
Amelie Penot, MDSeen in:
- Limoges, CHU Limoges
- Limoges, University Hospital, Limoges
Trials:- NCT05963061 (Sub-Investigator)
- NCT06130787 (Principal Investigator)
Conditions: -
Anne PARRY, MDSeen in:
- Annecy, CHRA
- Annecy, CHU Annecy-Genevois
- Annecy, Ch Annecy Genevois
Trials:- NCT03481868 (Principal Investigator)
- NCT06130787 (Principal Investigator)
- NCT02066454 (Sub-Investigator)
- NCT05963061 (Sub-Investigator)
-
Aspasia STAMATOULLAS, MDSeen in:
- Rouen, Centre Henri Becquerel
Trials:- NCT05226455 (Principal Investigator)
- NCT05768711 (Principal Investigator)
- NCT05782127 (Principal Investigator)
Conditions: -
Atchroue JOHNSON ANSAH, MDSeen in:
- Caen, CHU Caen
- Caen, University Hospital, Caen
Trials:- NCT03481868 (Principal Investigator)
- NCT06130787 (Principal Investigator)
- NCT05963061 (Sub-Investigator)
-
Aude CHARBONNIER, MDSeen in:
- Marseille, Institut Paoli-Calmettes
Trials:- NCT05963061 (Sub-Investigator)
- NCT06130787 (Principal Investigator)
Conditions: -
Blandine DELAVIGERIE, MDSeen in:
- Saint-Étienne, CHU SAINT-ETIENNE
Trials:- NCT06130787 (Sub-Investigator)
Conditions: -
Borhane Slama, MDSeen in:
- Provence-Alpes-Côte d'Azur, Avignon, Centre Hospitalier d'Avignon, Hôpital Henri Duffaut
Trials:- NCT06082804 (Sub-Investigator)
Conditions: -
Caroline LEJEUNESeen in:
- Saint-Étienne, CHU de Saint-Etienne
Trials:- NCT05130138 (Sub-Investigator)
Conditions: -
Christine Tosello, APNSeen in:
- Provence-Alpes-Côte d'Azur, Avignon, Centre Hospitalier d'Avignon, Hôpital Henri Duffaut
Trials:- NCT06082804 (Principal Investigator)
Conditions: -
Christophe WILLEKENS, MDSeen in:
- Villejuif, Institut Gustave Roussy
Trials:- NCT05768711 (Principal Investigator)
Conditions: -
Clément GAUDIN, MDSeen in:
- Toulouse, Institut Universitaire du Cancer de Toulouse - Oncopole
Trials:- NCT06130787 (Sub-Investigator)
Conditions: -
Clément LAHAYE, MDSeen in:
- Clermont-Ferrand, CHU de Clermont-Ferrand
Trials:- NCT06130787 (Sub-Investigator)
Conditions: -
Delphine LEBON, MDSeen in:
- Amiens, CHU d'Amiens
Trials:- NCT05768711 (Principal Investigator)
Conditions: -
Delphine REA, MDSeen in:
- Paris, Hopital Saint Louis
Trials:- NCT03481868 (Principal Investigator)
Conditions: -
Denis GuyotatSeen in:
- Saint-Étienne, CHU de Saint-Etienne
- Saint-Étienne, Centre Hospitalier Universitaire de Saint Etienne
Trials:- NCT05130138 (Sub-Investigator)
- NCT05091684 (Sub-Investigator)
- NCT03439371 (Sub-Investigator)
- NCT05963061 (Sub-Investigator)
-
Emanuelle DURON, MDSeen in:
- Paris, Groupe Hospitalier Paris Saclay - Site de Bicêtre
Trials:- NCT06130787 (Sub-Investigator)
Conditions: -
Emilie CHALAYERSeen in:
- Saint-Étienne, CHU de Saint-Etienne
Trials:- NCT05130138 (Sub-Investigator)
Conditions: -
Emmanuel GYAN, MD/PhDSeen in:
- Tours, CHU de Tours - Hôpital Bretonneau
Trials:- NCT05768711 (Principal Investigator)
- NCT05782127 (Principal Investigator)
-
Emmanuelle TAVERNIER, MDSeen in:
- Saint-Étienne, CHU SAINT-ETIENNE
- Saint-Étienne, Hématologie clinique Institut de Cancérologie de la Loire
Trials:- NCT03481868 (Principal Investigator)
- NCT04935684 (Principal Investigator)
-
Emmanuelle TAVERNIER TARDYSeen in:
- Saint-Étienne, CHU de Saint-Etienne
Trials:- NCT05130138 (Sub-Investigator)
Conditions:
Clinical Trials on Chronic Myeloid Leukemia
-
Newcastle UniversityBristol-Myers Squibb; Institute of Cancer Research, United Kingdom; Newcastle-upon-Tyne... and other collaboratorsCompletedMyeloid Leukemia, Chronic, Chronic PhaseUnited Kingdom
-
Asan Medical CenterTerminatedLeukemia, Chronic Myeloid | Myeloid Leukemia, Chronic, Chronic Phase | Myeloid Leukemia, Chronic, Accelerated PhaseKorea, Republic of
-
Bristol-Myers SquibbTerminatedLeukemia, Myeloid, ChronicSweden, United Kingdom, Russian Federation, France, Germany, Belgium, Portugal, Finland, Norway, Spain, Italy
-
University of BolognaCompletedMyeloid Leukemia, Chronic, Chronic-PhaseItaly
-
Bristol-Myers SquibbWithdrawnMyeloid Leukemia, Chronic, Chronic-PhaseUnited States
-
PETHEMA FoundationCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteIncyte Corporation; H. Jean Khoury Cure CML ConsortiumRecruitingChronic Myeloid Leukemia, Chronic Phase | Chronic Phase Chronic Myeloid LeukemiaUnited States
-
Emory UniversityTerminatedLeukemia | Chronic Myeloid Leukemia | Chronic Myelogenous LeukemiaUnited States
-
Fundacion Espanola para la Curacion de la Leucemia...Pfizer; Roche Farma, S.ATerminatedChronic Phase-Chronic Myeloid LeukemiaSpain
-
TakedaActive, not recruitingMyeloid Leukemia, Chronic, Chronic PhaseUnited States, Spain, Taiwan, Australia, Canada, Russian Federation, Sweden, Switzerland, Germany, United Kingdom, Poland, Korea, Republic of, Argentina, Hong Kong, Singapore, Italy, Chile, Czechia, Denmark, France, Portugal